41
Participants
Start Date
September 30, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
desvenlafaxine succinate sustained release
Two tablets of 25 mg, single administration, under fed condition
desvenlafaxine succinate sustained release
One tablet of 50 mg, single administration, under fed condition
desvenlafaxine succinate sustained release
Two tablets of 25 mg, single administration, under fast condition
desvenlafaxine succinate sustained release
One tablet of 50 mg, single administration, under fast condition
Pfizer Investigational Site, Brussels
Lead Sponsor
Pfizer
INDUSTRY